Isatuximab as a Treatment Option for MM

Isatuximab as a Treatment Option for MM
Don Photo

Don
3 anos 76 Visualizações
Categoria:
Descrição:
Paul Richardson, MD, Clinical Program Leader, Director of Clinical Research, Jerome Lipper Multiple Myeloma, Institute Physician, Harvard Medical School considers whether isatuximab can remain a treatment option for relapsed/refractory multiple myeloma (MM).